image: The new lentiviral vectors (LVs, black dots) harbor a protein named CD47 that protects them from the immune system. This material relates to a paper that appeared in the May 22, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by M. Milani at IRCCS San Raffaele Scientific Institute in Milan, Italy; and colleagues was titled, "Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates." view more
Credit: M. Milani <i>et al., Science Translational Medicine</i> (2019)